Jean-Nicolas Soret

Jean-Nicolas Soret


Practice areas


  • Bar admission: 2000
  • Graduated from ESCP Europe Business School and holds a Masters in Business Law and Taxation from the University of Paris II Panthéon-Assas
  • Partner at Reed Smith LLP
  • Partner at Altana since 2010

Areas of expertise:

  • Mergers & Acquisitions, Joint Venture, Company Law, Stock Exchange Law
  • Particular focus on cross-border transactions

Practice Areas:

  • Acquisition and sale of companies and groups
  • Strategic partnerships and joint venture agreements
  • Takeover bids
  • Transfer of non-strategic activities, group reorganisations
  • Long-term financing transactions for companies which are or are not listed on the stock exchange
  • Corporate governance and shareholder reorganisation
  • Growth equity
  • Post-acquisition litigation


  • French
  • English
  • Spanish


  • Our M&A team is notably featured in Décideurs (Leaders League ) (“Excellent” in transactions from €75M to €500M) and Legal 500. In December 2018, it was awarded, for the sixth year in a row, a 4-star ranking for M&A transactions up to €200M by Option Finance / Option Droit & Affaires.


  • “Foreign Direct Investment under Greater European and French Scrutiny” – The American Lawyer – May 2018
  • “Shareholder activism in France : a growing threat” – The American Lawyer (Focus International, Winter 2017) – January 2017
  • “Acquiring a carved out business in France, the usual suspects and the French touch”– The American Lawyer Magazine – May 2016
  • “FDI: France’s attractiveness is growing again” – The American Lawyer Magazine – October 2014
  • “BioAlliance Pharma and Topotarget enter into a Cross-Border Merger Agreement” – Lawyer Monthly – September 2014
  • “Fusions transfrontalières de sociétés cotées : quand l’Europe des entreprises devient une réalité” [Corporate cross-border mergers between listed companies: when Europe becomes a reality for companies] – Option Finance – September 2014
  • “The Initial Bond Offering, The future of SMEs financing” – Financier Worldwide – April 2013
  • “L’IBO, un excellent outil de financement alternatif pour les ETI” [The IBO, an excellent alternative financing instrument for medium-sized businesses] – Décideurs – March 2013
  • “Global M&A/France” – American Lawyer – January 2013
  • “Key concepts involved in acquisitions of ailing manufacturing companies in France” – Doing business in France – 2012 Edition
  • “Réussir ses carve out et transferts d’activités” [Successful carve outs and transfer of activities] – CF News – February 2012
  • “Alternext, un marché redynamisé” [Alternext, a revitalised market] – Décideurs – November 2010
  • “Communiquer sur ses difficultés, un exercice toujours délicat pour les sociétés cotées” [Disclosing your problems, an exercise which is never easy for listed companies] – Option Finance – September 2009
  • “Advantages Of A Dual Listing On NYSE-Euronext” – Law 360° – August 2008


  • The American Lawyer, ‘‘Keeping M&A afloat in France’’, January 2016
  • Option Finance, “The Bioalliance Pharma & Topotarget cross-border merger”, September 2014
  • The American Lawyer, “The French Paradox”, February 2014
  • The American Lawyer, “France, critical measures”, May 2013
  • Capital Finance, “Alternext a gagné en intérêt” [Alternext has become a more attractive market], July 2011

International Conferences:

  • February 2017, International Bar Association, Paris: speaker on a panel presentation on “European Share for Share Deals”
  • February 2014, International Bar Association, Paris: speaker on a panel presentation on “The colour of money: anti-bribery and M&A”
  • October 2013, International Bar Association, Boston: speaker on a panel presentation on “Letters of intent, confidentiality agreements and other pre-contractual agreements”


  • ESCP Europe Alumni
  • International Bar Association
  • Institut Français des Administrateurs (French Directors’ Association)

Linked news

View all news